Attached files

file filename
EX-99 - EXHIBIT 99.1 - TearLab Corpex99-1.htm


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


  

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

 

February 3, 2014

 


  

TEARLAB CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-51030

 

59-343-4771

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

9980 Huennekens Street, Suite 100

San Diego, CA 92121

(Address of principal executive offices, including zip code)

 

(858) 455-6006

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  



 

 
 

 

 

 

Item 2.02.      Results of Operations and Financial Condition.

 

On February 3, 2014, TearLab Corporation issued a press release announcing its preliminary financial results for its fourth quarter ended December 31, 2013.  A copy of this press release is attached hereto as Exhibit 99.1.

 

Item 9.01.      Financial Statements and Exhibits.

 

(d)  Exhibits.

  

Exhibit No.

 

Description

     

99.1

 

Press Release of TearLab Corporation dated February 3, 2014.

 

 

 
 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

   

TEARLAB CORPORATION

     
 

By:

/s/ William G. Dumencu

 
   

William G. Dumencu

Chief Financial Officer

 

Date: February 3, 2014